RT @RichardPAConway: Castrejon et al. Cancer risk with b/tsDMARD in BIOBADASER. Again not looking great for abatacept, R

Social Author Image
https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3.jpg
Tweet Author
RichardPAConway
Social Author Name
Richard Conway
Tweet Content
Castrejon et al. Cancer risk with b/tsDMARD in BIOBADASER. Again not looking great for abatacept, Rate ratio vs TNFi 2.2 (1.4-3.2). Age-adjusted HR 1.6 (1.0-2.6) @RheumNow #ACR22 Abstr#1752 https://t.co/PvBq2O9qPv https://t.co/XBfistBMhW
Links
Cancer Risk in Patients with Rheumatic Diseases Exposed to Different Biologic a… https://acrabstracts.org/abstract/cancer-risk-in-patients-with-rheumatic-diseas…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×